INDO AMERICAN PHARMACEUTICAL SOCIETY (EIN 222916788) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1986

Legal Domicile

Principal Officer

RAJESH SHAH

Phone

7323189628

Tax Period

2023-01-01 to 2023-12-31

INDO AMERICAN PHARMACEUTICAL SOCIETY, founded in 1986, is a small nonprofit in the Health Care sector that reported $142K in total revenue in fiscal year 2023. Revenue surged 106% from the prior year, signaling strong growth momentum. The organization ran a surplus of $44K, a strong 31% operating margin.

Mission

To keep its members informed of developments affecting pharmacies and arranges seminars and meetings for its members.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $4,700

Program Service Revenue $9,675

Investment Income $1,966

Other Revenue $125,172

TOTAL REVENUE $141,513

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $34,532

Other Expenses $97,577

TOTAL EXPENSES $97,577

Year-over-Year Comparison

	2023	2022	Change
Revenue	$141,513	$68,778	+1.1%
Expenses	$97,577	$78,517	+0.2%
Net Income	$43,936	$-9,739	-5.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RAJESH SHAH	President	4.00	Officer	$0	$0	$0
RAJENDRA PATEL	VICE PRESIDENT	2.00	Officer	$0	$0	$0
SANJAY TRIVEDI	2ND VICE PRESIDENT	2.00	Officer	$0	$0	$0
KIRAN DALAL	VICE PRESIDENT	2.00	Officer	$0	$0	$0
PRADIP ACHARYA	CHAIRMAN	2.00	Officer	$0	$0	$0
SUDHIR PATEL	SECRETARY	2.00	Officer Highest	$0	$0	$0
MAYUR PANDYA	TREASURER	2.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$141,513	$97,577	$773,391	$43,936
2022	$68,778	$78,517	$729,440	$-9,739
2021	$24,000	$58,664	$739,467	$-34,664
2020	$60,455	$26,976	$773,521	$33,479
2019	$58,655	$95,769	$740,041	$-37,114
2018	$216,218	$133,250	$777,154	$82,968

INDO AMERICAN PHARMACEUTICAL SOCIETY